Home › Funds › StepStone Group LP › OKUR
StepStone Group LP position in OKUR
ONKURE THERAPEUTICS INC-A · Health Care
StepStone Group LP reported holding 2,660,612 shares of OKUR (ONKURE THERAPEUTICS INC-A) in its Q2 2026 13F filing — a position valued at US$12.1M, representing 0.56% of its reported portfolio and ranking #6 among its reported holdings. StepStone Group LP has disclosed OKUR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How StepStone Group LP's OKUR position evolved
StepStone Group LP first disclosed a stake in OKUR in Q4 2024 at 491,938 shares (US$4.2M). The position peaked in Q2 2026 at 2,660,612 shares, worth US$12.1M. Across 7 filings, StepStone Group LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 2,660,612 shares valued at US$12.1M. Notable position changes include a 441% increase in Q1 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 491.94K | $4.23M | New |
| Q1 2025 | 491.94K | $2.12M | Hold |
| Q2 2025 | 491.94K | $1.18M | Hold |
| Q3 2025 | 491.94K | $1.35M | Hold |
| Q4 2025 | 491.94K | $1.35M | Hold |
| Q1 2026 | 2.66M | $11.01M | Add |
| Q2 2026 | 2.66M | $12.13M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OKUR and 13F data
OKUR (ONKURE THERAPEUTICS INC-A) is a Health Care company. 74 other funds we track also report a position in OKUR — the largest reported positions include BVF INC/IL (US$14.8M), ACORN CAPITAL ADVISORS, LLC (US$12.9M), ADAR1 Capital Management, LLC (US$10.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OKUR
- BVF INC/IL 3.24M sh · $14.76M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.84M sh · $12.95M · Q2 2026
- ADAR1 Capital Management, LLC 2.24M sh · $10.21M · Q2 2026
- Vivo Capital, LLC 1.93M sh · $8.79M · Q2 2026
- Trails Edge Capital Partners, LP 1.44M sh · $6.56M · Q2 2026
- Sio Capital Management, LLC 1.08M sh · $4.92M · Q2 2026
- Prosight Management, LP 978.99K sh · $4.46M · Q2 2026
- NEA Management Company, LLC 478.55K sh · $2.18M · Q2 2026
- Sofinnova Investments, Inc. 321.69K sh · $1.47M · Q2 2026
- Carlyle Group Inc. 269.89K sh · $1.23M · Q2 2026
- Rosalind Advisors, Inc. 150.00K sh · $684.00K · Q2 2026
- Aisling Capital Management LP 88.61K sh · $404.05K · Q2 2026
More on StepStone Group LP
FAQ
How long has StepStone Group LP held OKUR?
StepStone Group LP has disclosed OKUR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is StepStone Group LP's current position in OKUR?
As of Q2 2026, StepStone Group LP holds 2.66M shares of OKUR (ONKURE THERAPEUTICS INC-A), valued at $12.13M, representing 0.56% of its reported portfolio and ranking #6.
Has StepStone Group LP been buying or selling OKUR?
In the latest 13F filing (Q2 2026), StepStone Group LP held unchanged its position in OKUR. The position peaked in Q2 2026 at 2.66M shares.
Which other funds hold OKUR?
Other major institutional holders of OKUR include BVF INC/IL, ACORN CAPITAL ADVISORS, LLC, ADAR1 Capital Management, LLC, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.